e-Edition
Obituaries
Photo Gallery
Magazines
News Crew
Paywall Login
Login to Comment
Register
December 15th, 2015
Menu
Home
News
Sports
Business
Entertainment
Federal Election
Classifieds
Life
Commentary
Contact
Local News
Provincial News
National News
World News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
News releases from Biogen Canada
Patients living with Spinal Muscular Atrophy (SMA) in the province of Saskatchewan gain access to SPINRAZA™ (nusinersen)
April 22, 2019
Tickers
BIIB
From
PR Newswire
Biogen Responds to CADTH’s updated recommendation regarding coverage for SPINRAZA
March 01, 2019
Today, CADTH publicly released updated recommendations that could inform provincial jurisdictions’ decisions on the public reimbursement of SPINRAZA (nusinersen), the first and only approved treatment...
Tickers
BIIB
From
GlobeNewswire News Releases
Biogen Applauds Quebec Decision to Cover SPINRAZA™ (nusinersen) for a broad population of SMA Patients
December 20, 2018
Biogen Canada applauds the Government of Quebec’s decision to cover SPINRAZA for a broad population of patients with Spinal Muscular Atrophy (SMA) in the province. The announcement was made by the...
Tickers
BIIB
From
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.